[JackeJR]

Not exactly. What Theranos has done is to make clear in its aftermath why the problem of making a diagnosis from a single drop of blood is difficult. In short, the sample size is too small and may not contain biomarkers of the diseases of interest even if they are present in the body. Unless this advancement in its application can show how and why this is not a problem, there will be resistance towards accepting what is being put out without further substantiating evidence.